The transgender community faces unique challenges in HIV care, compounded by racial and ethnic health disparities and a lack of culturally competent providers. Transgender leadership is essential to address the dire HIV epidemic in transgender communities, improve transgender health outcomes, and solidify transgender power in our society.

Following principles of Meaningful Involvement of People Living with HIV/AIDS (MIPA), transgender individuals are involved in decision-making at all levels of this project. We will increase transgender leadership within organizations, community planning bodies, and networks.

Specifically, we will:

We are supported by the Janssen Pharmaceutical Companies of Johnson & Johnson.